HHLR Advisors, Ltd. 13D/13G Filings for Leap Therapeutics, Inc. (LPTX)

HHLR Advisors, Ltd. 13D and 13G filings for Leap Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
4:05 pm
Sale		 2021-12-31 13G Leap Therapeutics, Inc.
LPTX		 HHLR Advisors, Ltd. 0
0.000%		 -371,624decrease
(Position Closed)		 Filing
2021-02-16
4:25 pm
Purchase		 2020-12-31 13G Leap Therapeutics, Inc.
LPTX		 HHLR Advisors, Ltd. 371,624
6.200%		 371,624increase
(New Position)		 Filing